Investments
1Portfolio Exits
1Latest East Bay Municipal Utility District News
Apr 27, 2022
By Web Staff Click here for updates on this story OAKLAND, California (KPIX) — East Bay Municipal Utility District (EBMUD) on Tuesday declared a Stage 2 drought, which means mandatory water restrictions and likely additional costs for the utility’s 1.4 million customers. During the height of the last drought, EBMUD customers faced mandatory cutbacks of The post EBMUD Enacts Mandatory Water Restrictions; Drought Surcharge May Follow appeared first on KTVZ.
East Bay Municipal Utility District Investments
1 Investments
East Bay Municipal Utility District has made 1 investments. Their latest investment was in La Jolla Pharmaceutical Company as part of their Unattributed VC - IV on January 1, 2002.
East Bay Municipal Utility District Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
1/18/2002 | Unattributed VC - IV | La Jolla Pharmaceutical Company | $51.59M | Yes | Alfred I. duPont Testamentary Trust, AWM Investment Company, Bain Capital Public Equity, Deerfield Management, Deka Investment, DekaTeam-BioTech, EGS Healthcare Capital Partners, ING, J.P. Morgan Chase & Co., Memorial Hospital Of South Bend, Nemours Foundation, RS Investments, Safeco, SF Capital Group, UBS, Undisclosed Investors, Utah Retirement Systems, and Zeke |
Date | 1/18/2002 |
|---|---|
Round | Unattributed VC - IV |
Company | La Jolla Pharmaceutical Company |
Amount | $51.59M |
New? | Yes |
Co-Investors | Alfred I. duPont Testamentary Trust, AWM Investment Company, Bain Capital Public Equity, Deerfield Management, Deka Investment, DekaTeam-BioTech, EGS Healthcare Capital Partners, ING, J.P. Morgan Chase & Co., Memorial Hospital Of South Bend, Nemours Foundation, RS Investments, Safeco, SF Capital Group, UBS, Undisclosed Investors, Utah Retirement Systems, and Zeke |
Sources |
East Bay Municipal Utility District Portfolio Exits
1 Portfolio Exit
East Bay Municipal Utility District has 1 portfolio exit. Their latest portfolio exit was La Jolla Pharmaceutical Company on February 06, 2006.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
2/6/2006 | IPO |
Date | 2/6/2006 |
|---|---|
Exit | IPO |
Companies | |
Valuation | |
Acquirer | |
Sources |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.